Subcutaneous vs Intramuscular Administration in Research Models
Route selection in published protocols and what each means for volume and absorption.
By PX1 Research Team · August 4, 2026
Subcutaneous vs Intramuscular Administration in Research Models
Subcutaneous
The dominant route in the literature for peptide research: small volumes, slower absorption, and the route most reported protocols specify.
Intramuscular
Used where faster absorption or larger volume is required. Less common in peptide-model literature.
Volume limits
Subcutaneous volumes in published models are typically under 1 mL per site, which is why concentration choice at reconstitution matters.
How PX1 documents every lot
Every PX1 lot ships with HPLC purity, LC-MS identity, residual solvent, moisture (Karl Fischer), sterility and endotoxin data. Lot documentation is published at /purity-reports, /endotoxin-reports and /coa. Synthesis, purification, lyophilization and vial fill happen in U.S. facilities — see /manufacturing-process.
Research use only. PX1 Research supplies compounds for laboratory and in-vitro research. Nothing here is medical advice, a dosing recommendation, or an offer for human or veterinary use. Figures cited are reported from published laboratory literature.